Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.

MLA

Narita, Ichiei, et al. “Hyporesponsiveness to Erythropoiesis-Stimulating Agent in Non-Dialysis-Dependent CKD Patients: The BRIGHTEN Study.” PloS One, vol. 17, no. 11, Nov. 2022, p. e0277921. EBSCOhost, https://doi.org/10.1371/journal.pone.0277921.

APA

Narita, I., Hayashi, T., Maruyama, S., Masaki, T., Nangaku, M., Nishino, T., Sato, H., Sofue, T., Wada, T., Imai, E., Iwasaki, M., Mizuno, K., Hase, H., Kamouchi, M., Yamamoto, H., Kagimura, T., Tanabe, K., Kato, H., Wada, T., … Tsubakihara, Y. (2022). Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study. PloS One, 17(11), e0277921. https://doi.org/10.1371/journal.pone.0277921

Chicago

Narita, Ichiei, Terumasa Hayashi, Shoichi Maruyama, Takao Masaki, Masaomi Nangaku, Tomoya Nishino, Hiroshi Sato, et al. 2022. “Hyporesponsiveness to Erythropoiesis-Stimulating Agent in Non-Dialysis-Dependent CKD Patients: The BRIGHTEN Study.” PloS One 17 (11): e0277921. doi:10.1371/journal.pone.0277921.